Sandoz will maintain stable pricing for coronavirus-related essential medicines that it markets, CEO Richard Saynor has pledged, amid ongoing concerns over the potential short-term and longer-term impacts of the outbreak on the supply chain.
As “the number one provider of off-patent antibiotic medicines worldwide,” Sandoz said it was “making a public commitment to ensure stable pricing for a basket of essential medicines the company markets, which may help to treat coronavirus patients, amid growing
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?